Back
Equillium 10K Form
Sell
34
EQ
Equillium
Last Price:
0.72
Seasonality Move:
46.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EQ News And Ratings
See the #1 stock for the next 7 days that we like better than EQ
EQ Financial Statistics
Sales & Book Value
| Annual Sales: | $36.08M |
|---|---|
| Cash Flow: | $-7.66M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.65 |
| Price / Book: | 1.1 |
Profitability
| EPS (TTM): | -0.14020 |
|---|---|
| Net Income (TTM): | $-4.62M |
| Gross Margin: | -- |
| Return on Equity: | -20.35% |
| Return on Assets: | -10.18% |
Equillium Earnings Forecast
Key Equillium Financial Ratios
- The Research & Development expenses have been 102.65% of Revenue.
- The Interest Expense is -3.68% of Operating Income.
- The Net Earning history of EQ is -36.96% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Equillium Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EQ |
| CUSIP: | 29446K |
| Website: | equilliumbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.04 |
| Quick Ratio: | 2.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |